Catalent, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference

SOMERSET, N.J.–(BUSINESS WIRE)–Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products, today announced that Matthew Walsh, Executive
Vice President & Chief Financial Officer, will present at the 29th
Annual Piper Jaffray Healthcare Conference at 2:00 p.m. EST on Tuesday,
November 28, 2017 in New York City.

A live webcast of the presentation will be accessible through the
Company’s website at http://investor.catalent.com
and will be available for replay following the event.

About Catalent, Inc.

Catalent is the leading global provider of advanced delivery
technologies and development solutions for drugs, biologics and consumer
health products. With over 80 years serving the industry, Catalent has
proven expertise in bringing more customer products to market faster,
enhancing product performance and ensuring reliable clinical and
commercial product supply. Catalent employs over 10,000 people,
including over 1,400 scientists, at more than 30 facilities across 5
continents and in fiscal 2017 generated more than $2 billion in annual
revenue. Catalent is headquartered in Somerset, N.J. For more
information visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

Contacts

Investor:
Catalent, Inc.
Thomas Castellano, (732) 537-6325
investors@catalent.com